Medical information Clinical review pending

Cytogenetics

CMyc Oncogene

The CMyc Oncogene test helps identify genetic changes linked to various cancers, aiding in understanding tumor behavior and guiding treatment. Available across Kenya.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Tumor tissue sample. Confirm specific requirements with the laboratory before booking.
Results: Approximately 7-8 days. Confirm exact turnaround time with the laboratory before booking.
Preparation: Requires a doctor's prescription. No specific patient preparation is needed for the sample collection itself, but follow your doctor's instructions regarding the biopsy or surgery to obtain the tissue.

Test priceKSh 18,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the CMyc Oncogene test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Patients diagnosed with certain cancers (e.g., lymphomas, solid tumors)
✓Individuals with a family history of cancer
✓Patients with symptoms suggestive of cancer
✓Guiding personalized cancer treatment plans
✓Prognosis assessment in cancer patients

In plain language

What this test helps you understand

Identifies genetic alterations in the CMyc oncogene associated with cancer development and progression. Provides insights into tumor behavior, potentially influencing treatment decisions and prognosis.

The CMyc oncogene test is a diagnostic tool used in oncology to identify genetic abnormalities associated with cancer development and progression. Understanding the status of the CMyc oncogene provides insights into tumor behavior, influencing treatment decisions and patient management. This test detects alterations in the CMyc oncogene, which plays a role in cell growth and proliferation. By analyzing tumor tissue, it helps identify mutations or amplifications that may indicate a higher risk for aggressive cancer behavior. This test is particularly relevant for patients diagnosed with certain cancers, such as lymphomas and solid tumors. It can also be considered by individuals with a family history of cancer or those experiencing specific symptoms. Taking this test can aid in early detection, guide personalized treatment plans, provide prognostic information, and help monitor therapy response. Results indicate the presence or absence of genetic alterations. Discuss results with your healthcare provider to understand their implications and next steps. Please note that this test requires a doctor's prescription.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationRequires a doctor's prescription. No specific patient preparation is needed for the sample collection itself, but follow your doctor's instructions regarding the biopsy or surgery to obtain the tissue.

SampleTumor tissue sample. Confirm specific requirements with the laboratory before booking.

MethodologyMolecular genetic testing techniques are used to analyze the CMyc oncogene in the provided tumor tissue sample. Confirm specific methodology with the laboratory before booking.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test detects specific alterations in the CMyc oncogene. It does not provide a complete picture of all genetic factors involved in cancer. Results must be interpreted in the context of the patient's clinical presentation and other diagnostic findings. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

CMyc is a gene that plays a role in cell growth and division. Changes in this gene can be associated with the development and progression of certain cancers.

This test is typically ordered by doctors for patients diagnosed with specific types of cancer, particularly lymphomas and some solid tumors, to help understand the tumor's characteristics.

A positive result indicates the presence of specific alterations in the CMyc gene. Your doctor will interpret this result in the context of your overall health and diagnosis to discuss its implications.

Yes, this test requires a prescription from a qualified healthcare provider.

The test requires a tumor tissue sample, usually obtained through a biopsy or surgery. Your doctor will advise on the appropriate procedure.

Results are typically available within approximately 7-8 days, but this can vary. Confirm the exact turnaround time with the laboratory.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp